Co-founder and CEO, Biogenes Technologies
For leading in synthetic antibody diagnostics
Biotechnologist Adrian Joseph aims to shake up the science of diagnostics and redefine global healthcare accessibility. His company, Biogenes Technologies, is revolutionising the medical industry by using AI and software to develop synthetic antibodies. The company was the first to commercialise software-designed synthetic antibodies, a significant leap forward in diagnostics.
Impacted Industries
Healthcare & Sciences
